UBS ASSET MANAGEMENT AMERICAS INC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 221 filers reported holding IMMUNOGEN INC in Q3 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS INC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$4,856,536
+330.5%
306,020
+4.2%
0.00%
+100.0%
Q2 2023$1,128,1530.0%293,7900.0%0.00%0.0%
Q1 2023$1,128,153
-7.9%
293,790
+18.9%
0.00%0.0%
Q4 2022$1,225,511
-99.9%
247,079
+1.0%
0.00%0.0%
Q3 2022$1,169,198,000
+18.2%
244,602
+11.3%
0.00%0.0%
Q2 2022$988,958,000
+11.0%
219,768
+17.4%
0.00%
Q1 2022$890,720,000
-35.8%
187,1260.0%0.00%
-100.0%
Q4 2021$1,388,475,000
+52.9%
187,126
+16.9%
0.00%
Q3 2021$907,953,000
-12.4%
160,133
+1.8%
0.00%
Q2 2021$1,036,482,000
-12.0%
157,281
+8.2%
0.00%
-100.0%
Q1 2021$1,177,699,000
+12.8%
145,395
-10.2%
0.00%
Q4 2020$1,043,906,000
+79.2%
161,8460.0%0.00%
Q3 2020$582,646,000
-21.7%
161,8460.0%0.00%
Q2 2020$744,492,000
+45.3%
161,846
+7.7%
0.00%
Q1 2020$512,300,000
-46.6%
150,235
-20.0%
0.00%
-100.0%
Q4 2019$958,699,000
+164.5%
187,796
+25.4%
0.00%
Q3 2019$362,419,000
+26.3%
149,760
+13.3%
0.00%
Q2 2019$286,917,000
-19.9%
132,2200.0%0.00%
Q1 2019$358,316,000
-32.8%
132,220
+19.1%
0.00%
Q4 2018$532,949,000
-40.3%
111,031
+17.9%
0.00%
-100.0%
Q3 2018$892,169,000
+2.4%
94,210
+5.3%
0.00%0.0%
Q2 2018$870,932,000
+0.2%
89,510
+8.4%
0.00%0.0%
Q1 2018$869,057,000
+201.3%
82,610
+83.6%
0.00%
Q4 2017$288,476,000
-24.9%
45,004
-10.4%
0.00%
Q3 2017$384,328,000
+9.4%
50,239
+1.7%
0.00%
Q2 2017$351,213,000
+33.3%
49,397
-27.5%
0.00%
Q1 2017$263,535,000
+479054.5%
68,097
+148.6%
0.00%
Q4 2016$55,000
-69.1%
27,397
-58.9%
0.00%
Q3 2016$178,000
-13.2%
66,5970.0%0.00%
Q2 2016$205,000
-63.9%
66,5970.0%0.00%
-100.0%
Q1 2016$568,000
-41.0%
66,597
-6.1%
0.00%0.0%
Q4 2015$962,000
+45.8%
70,897
+3.2%
0.00%0.0%
Q3 2015$660,000
-20.5%
68,697
+19.1%
0.00%0.0%
Q2 2015$830,000
+57.2%
57,697
-2.2%
0.00%0.0%
Q1 2015$528,000
+177.9%
58,997
+89.7%
0.00%
Q4 2014$190,000
-42.2%
31,0970.0%0.00%
Q3 2014$329,000
-10.6%
31,0970.0%0.00%
Q2 2014$368,000
-20.7%
31,0970.0%0.00%
Q1 2014$464,000
+8.4%
31,097
+6.5%
0.00%
Q4 2013$428,000
-16.4%
29,197
-3.0%
0.00%
-100.0%
Q3 2013$512,000
+2.6%
30,0970.0%0.00%0.0%
Q2 2013$499,00030,0970.00%
Other shareholders
IMMUNOGEN INC shareholders Q3 2021
NameSharesValueWeighting ↓
Redmile Group, LLC 17,503,417$277,779,22813.22%
Fairmount Funds Management LLC 5,929,592$94,102,62511.32%
CM Management, LLC 500,000$7,935,0008.42%
SILVERARC CAPITAL MANAGEMENT, LLC 1,307,435$20,748,9936.29%
Altium Capital Management LP 725,000$11,505,7506.00%
RA Capital Management 13,322,288$211,424,7114.16%
TANG CAPITAL MANAGEMENT LLC 1,500,000$23,805,0003.36%
BRIDGER MANAGEMENT, LLC 467,220$7,414,7812.73%
Birchview Capital, LP 190,000$3,015,3002.57%
Boxer Capital, LLC 2,961,000$46,991,0702.50%
View complete list of IMMUNOGEN INC shareholders